Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interleukin-2 receptor beta subunit (IL-2Rβ), also known as CD122, is a type I membrane protein that forms a critical component of the interleukin-2 receptor complex. It plays an essential role in mediating immune responses, particularly those involving T cells and natural killer (NK) cells. It binds interleukin-2 (IL-2) as part of the multi-subunit complex and also participates in the interleukin-15 receptor complex. Therapeutic manipulation of this pathway has been central both for immunostimulation (e.g., cancer immunotherapy using recombinant human IL-2) and immunosuppression strategies.
Agonism (with IL-2), modulation of IL-2 signaling
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 2 Receptor Beta Subunit (IL-2Rβ).